1 - 25 of 258
Number of results to display per page
TitleCreatorRelation Is Part Of
1 Involvement in Multiple SclerosisNorman J. SchatzNANOS 1982: Various Subjects Symposium (Session 2)
2 The Association Between Multiple Sclerosis and Uveitis (.pdf)Tine Gadegaard Olsen; Jette FrederiksenNANOS Annual Meeting 2016: Poster Presentations
3 Contemporary Imaging of Multiple Sclerosis Using Triple-dose and 3.0 T: Preliminary Safety Data from the "BECOME" StudyRoger E. Turbin; Nilay S. Sethi; Diego N. Cadavid; Leo J. Wolansky; Jiang Liu; George Joseph; Mohammad H. Haghighi; Joan H. Skurnick; Larry P. Frohman; Stuart D. Cook
4 Immunology of Multiple SclerosisBarry G. W. AmasonNANOS 1996: Multiple Sclerosis Symposium
5 Should We Ever Consider Stopping Disease-Modifying Treatment for MS?Robert ShinNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
6 The predictive value of brain MRI in acute optic neuritis for developing multiple sclerosisJette L. Frederiksen; Nadia N. PoulsenNANOS 2014: Poster Presentations
7 Emerging Therapies of Multiple SclerosisJeffrey Bennett, MD, PhDNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
8 Pediatric Optic Neuritis and Risk of Multiple SclerosisGrant T. LiuNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
9 Comparison of Visual Function Tests in an MS CohortLaura J. Balcer, MD, MSCE; Ligia Nano-Schiavi, CO; Dina A. Jacobs, MD; Clyde E. Markowitz, MD; Dorothea C. Pfohl, RN; Steven L. Galetta, MD; Maureen G. Maguire, PhDNANOS 2003: Scientific Platforms Presentations I
10 Immunomodulatory Therapies and Low Dose Azathioprine Reverse Partially and Significantly Visual and Neurologic Deficits in Progressive Forms of Multiple SclerosisDan Milder, MD
11 Multiple Sclerosis - Diagnosis and PrognosisWayne T. Cornblath, MDNANOS 1996: Multiple Sclerosis Symposium
12 Visual Dysfunction in MS Is Associated with Abnormalities in Normal-Appearing Gray and White MatterLaura J. Balcer; Gregory F. Wu; Jayaram K. Udupa; Tianhu Lei; Tad Iwanaga; Eric D. Schwartz; Lisa M. Desiderio; M. Ligia Nano-Schiavi; Steven L. Galetta; Maureen G. Maguire; Gary R. Cutter
13 Visual Function and Disease Phenotype in Multiple SclerosisGregory F. Wu, MD, PhD; M. Ligia Nano-Schiavi, CO; Steven L. Galetta, MD; Jeffrey A. Cohen, MD; Laura J. Balcer, MD, MSCENANOS 2004: Scientific Platform Presentations (Session 2)
14 Existing Therapies for Treatment of MSAri J. Green, MDNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
15 Extra-Axonal Ocular Damage Quantification by Multifocal Electroretinography in Chronic Progressive Multiple SclerosisArielle R. Spitze; Nagham Al-Zubidi; Sushma Yalamanchili; Fiona Costello; Andrew G. LeeNANOS 2013: Poster Presentations
16 Starting and Switching Multiple Sclerosis TherapySteven L. Galetta, MDNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
17 The Optic Nerve: "Tip of the Iceberg" of DemyelinationMark J. MorrowNANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
18 Neuromyelitis Optica Spectrum Disorders: Diagnosis and TreatmentDean M. Wingerchuk, MD, MSc, FRCP(C)NANOS 2011: Multiple Sclerosis & Neuromyelitis Optica: The State of the Art
19 Analysis of the Ten-Year Evaluation of the ONTT PatientsMark J. KupersmithNANOS 2004: Scientific Platform Presentations (Session 2)
20 Comparison of Multifocal Objective Pupil Perimetry and MRI in Multiple SclerosisChristian J. Lueck; Eman Ali; Cristian Voicu; Andrew James; Andrew Janke; Teddy MaddessNANOS 2012: Scientific Platform Presentations (Session II)
21 Immunoglobin Heavy-Chain Repertoire Bias and the Risk of Demyelinating Disease in Isolated Optic NeuritisJ. Bennett; A. Ritchie; K. Haubold; D. Gilden; G. OwensNANOS 2006: Scientific Platform Presentations (Session I)
22 Management of Acute Optic Neuritis : Survey of Ophthalmologists and Neurologists in the South-East United StatesBusaba Sathornsumetee; Carolyn D. Drews-Botsch; Seegar Swanson; Nancy J. Newman; Valerie BiousseNANOS 2006: Poster Presentations
23 Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis (MS)Marco Zarbin; Anthony T. Reder; William Collins; Gordon Francis; Xiaoli Zhang; Ludwig Kappos; Jeffrey A. CohenNANOS 2012: Poster Presentations
24 Opsoclonus and Ocular Flutter in Multiple SclerosisChristian Wertenbaker, MD; Marc Ellman, MDNANOS 2003: Poster Presentations
25 Advances in MS TherapyBart K. Chwalisz, MDNANOS Annual Meeting 2022: State of the Art in Neuro-Ophthalmic Disease
1 - 25 of 258